CliffBio

Heron Therapeutics

Patent cliffs & loss of exclusivity

Heron Therapeutics is a San Diego, California-based pharmaceutical company offering a polymer-based drug delivery platform.

Company

Legal NameHeron Therapeutics, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/heron-therapeutics-inc
Full Address4242 Campus Point Court, Suite 200 San Diego, CA 92121, USA
LinkedIn URLhttps://www.linkedin.com/company/heron-therapeutics-inc-
Pitchbook URLhttps://pitchbook.com/profiles/company/41049-82
Ticker SymbolHRTX
Official Websitehttp://herontx.com

6 upcoming patent cliffs

DrugIngredientTypeCliff
  1. APONVIEAPREPITANTSmall mol.Sep 2035
  2. CINVANTIAPREPITANTSmall mol.Sep 2035
  3. ZYNRELEF KITBUPIVACAINE; MELOXICAMSmall mol.Apr 2036
  4. ZYNRELEF KITBUPIVACAINE; MELOXICAMSmall mol.Apr 2036
  5. ZYNRELEF KITBUPIVACAINE; MELOXICAMSmall mol.Apr 2036
  6. ZYNRELEF KITBUPIVACAINE; MELOXICAMSmall mol.Apr 2036
  7. SUSTOLGRANISETRONSmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Heron Therapeutics — patent cliffs & loss of exclusivity | CliffBio